Hypoxia-Response Plasmid Vector Producing bcl-2 shRNA Enhances the Apoptotic Cell Death of Mouse Rectum Carcinoma
スポンサーリンク
概要
- 論文の詳細を見る
Hypoxia-induced gene expression frequently occurs in malignant solid tumors because they often have hypoxic areas in which circulation is compromised due to structurally disorganized blood vessels. Hypoxia-response elements (HREs) are responsible for activating gene transcription in response to hypoxia. In this study, we constructed a hypoxia-response plasmid vector producing short hairpin RNA (shRNA) against B-cell leukemia/lymphoma-2 (bcl-2), an anti-apoptotic factor. The hypoxia-response promoter was made by inserting tandem repeats of HREs upstream of cytomegalovirus (CMV) promoter (HRE-CMV). HRE-CMV shbcl-2 vector consisted of bcl-2 shRNA under the control of HRE-CMV promoter. In hypoxic mouse rectum carcinoma cells (colon-26), the production of bcl-2 shRNA driven by HRE-CMV promoter was approximately 2-fold greater than that driven by CMV promoter. A single intratumoral (i.t.) injection of 40 μg HRE-CMV shbcl-2 to colon-26 tumor–bearing mice caused apoptotic cell death, and repetitive treatment with HRE-CMV shbcl-2 (40 μg/mouse, i.t.) also significantly suppressed the growth of colon-26 tumor cells implanted in mice. Apoptotic and anti-tumor effects were not observed in tumor-bearing mice treated with CMV shbcl-2. These results reveal the ability of HRE-CMV shbcl-2 vector to suppress the expression of bcl-2 in hypoxic tumor cells and suggest the usefulness of our constructed hypoxia-response plasmid vector to treat malignant tumors.[Supplementary Figures: available only at http://dx.doi.org/10.1254/jphs.10054FP]
著者
-
KOYANAGI Satoru
Pharmaceutics, Division of Clinical Pharmacy, Department of Medico-Pharmaceutical Sciences, Faculty
-
OHDO Shigehiro
Pharmaceutics, Division of Clinical Pharmacy, Department of Medico-Pharmaceutical Sciences, Faculty
-
MATSUNAGA Naoya
Pharmaceutics, Division of Clinical Pharmacy, Department of Medico-Pharmaceutical Science, Faculty o
-
Ohdo Shigehiro
Pharmaceutics Div. Of Clinical Pharmacy Dep. Of Medico-pharmaceutical Sciences Fac. Of Pharmaceutica
-
Fujioka Takashi
Department Of Neuroscience Yamaguchi University School Of Medicine
-
Fujioka Takashi
Pharmaceutics, Division of Clinical Pharmacy, Department of Medico-Pharmaceutical Sciences, Faculty
-
Okazaki Hiroyuki
Pharmaceutics, Division of Clinical Pharmacy, Department of Medico-Pharmaceutical Sciences, Faculty
-
Koyanagi Satoru
Department Of Medico-pharmaceutical Sciences Kyushu University
-
Fujioka Toshihiro
National Institute Of Genetics And The Graduate University For Advanced Studies
-
Ohdo Shigehiro
Department Of Clinical Pharmacokinetics Division Of Pharmaceutical Sciences Kyushu University
-
Koyanagi Satoru
Pharmaceutics Division Of Clinical Pharmacy Department Of Medico-pharmaceutical Science Faculty Of P
-
Matsunaga Naoya
Department Of Pharmaceutics Graduate School Of Pharmaceutical Sciences Kyushu University
-
OKAZAKI Hiroyuki
Department of Pharmaceutics, Graduate School of Pharmaceutical Sciences, Kyushu University
-
Okazaki Hiroyuki
Department Of Pharmaceutics Graduate School Of Pharmaceutical Sciences Kyushu University
-
Fujioka Takashi
Department Of Pharmaceutics Graduate School Of Pharmaceutical Sciences Kyushu University
-
Fujioka Takashi
Department of Pharmaceutics, Graduate School of Pharmaceutical Sciences, Kyushu University, Japan
-
Okazaki Hiroyuki
Department of Pharmaceutics, Graduate School of Pharmaceutical Sciences, Kyushu University, Japan
-
Koyanagi Satoru
Department of Pharmaceutics, Graduate School of Pharmaceutical Sciences, Kyushu University, Japan
-
Koyanagi Satoru
Department of Biochemistry, Faculty of Pharmaceutical Sciences, Fukuoka University
-
Matsunaga Naoya
Department of Pharmaceutics, Graduate School of Pharmaceutical Sciences, Kyushu University, Japan
-
Ohdo Shigehiro
Department of Pharmaceutics, Graduate School of Pharmaceutical Sciences, Kyushu University, Japan
関連論文
- Hypoxia-Response Plasmid Vector Producing bcl-2 shRNA Enhances the Apoptotic Cell Death of Mouse Rectum Carcinoma
- ＜Symposium I＞Vascular endothelial growth factor（ VEGF） expression is negatively regulated by basic-helix-loop-helix（ bHLH）transcription factor DEC2
- Role of Glucocorticoid Receptor in the Regulation of Cellular Sensitivity to Irinotecan Hydrochloride
- Glucocorticoid Is Involved in Food-Entrainable Rhythm of μ-Opioid Receptor Expression in Mouse Brainstem and Analgesic Effect of Morphine
- Modulation of Circadian Rhythm of DNA Synthesis in Tumor Cells by Inhibiting Platelet-Derived Growth Factor Signaling
- Chronopharmaceutics: Pharmaceutics Focused on Biological Rhythm
- Cortical spreading depression affects Fos expression in the hypothalamic paraventricular nucleus and the cerebral cortex of both hemispheres
- Daily Expression of mRNA_s for the Mammalian Clock Genes Per2 and Clock in Mouse Suprachiasmatic Nuclei and Liver and Human Peripheral Blood Mononuclear Cells
- Utility of a Rectal Suppository Containing the Antiepileptic Drug Zonisamide
- Cell-Cycle-Dependent Pharmacology of Methotrexate in HL-60
- Chronotoxicity of Methotrexate in Mice and Its Relation to Circadian Rhythm of DNA Synthesis and Pharmacokinetics
- Chronotoxicity of Sodium Valproate in Pregnant Mouse and Embryo
- Hypoxia-Response Plasmid Vector Producing bcl-2 shRNA Enhances the Apoptotic Cell Death of Mouse Rectum Carcinoma
- Relationship Between 24-Hour Rhythm in Antiviral Effect of Interferon-β and Interferon-α/β Receptor Expression in Mice
- Circadian Rhythms in the CNS and Peripheral Clock Disorders : Chronopharmacological Findings on Antitumor Drugs
- Chronopharmacological study of sodium valproate in mice: Dose-concentration-response relationship.
- Chronotoxicity and Chronopharmacokinetics of Methotrexate in Mice: Modification by Feeding Schedule.
- An influencing factor to predict plasma valproate concentrations: Circadian stage-dependent kinetics.:Circadian Stage-Dependent Kinetics